Cargando…
Dapsone‐ and nitroso dapsone‐specific activation of T cells from hypersensitive patients expressing the risk allele HLA‐B*13:01
BACKGROUND: Research into drug hypersensitivity associated with the expression of specific HLA alleles has focussed on the interaction between parent drug and the HLA with no attention given to reactive metabolites. For this reason, we have studied HLA‐B*13:01‐linked dapsone hypersensitivity to (a)...
Autores principales: | Zhao, Qing, Alhilali, Khetam, Alzahrani, Abdulaziz, Almutairi, Mubarak, Amjad, Juwaria, Liu, Hong, Sun, Yonghu, Sun, Lele, Zhang, Huimin, Meng, Xiaoli, Gibson, Andrew, Ogese, Monday O., Kevin Park, B., Liu, Jianjun, Ostrov, David A., Zhang, Furen, Naisbitt, Dean J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767778/ https://www.ncbi.nlm.nih.gov/pubmed/30844087 http://dx.doi.org/10.1111/all.13769 |
Ejemplares similares
-
Dapsone hypersensitivity syndrome
por: Zhao, Qing, et al.
Publicado: (2023) -
Activation of human CD8+ T-cells with nitroso dapsone-modified HLA-B*13:01-binding peptides()
por: Almutairi, Mubarak, et al.
Publicado: (2023) -
Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia
por: Krismawati, Hana, et al.
Publicado: (2020) -
Dapsone hypersensitivity syndrome: A rare life threatening complication of dapsone therapy
por: Vinod, Kolar Vishwanath, et al.
Publicado: (2013) -
Severe dapsone hypersensitivity syndrome in a child
por: Choi, So Yoon, et al.
Publicado: (2013)